Semi-Annual Statement Of Income And Retained Earnings

STELLA PHARMA CORPORATION - Filing #7371918

Concept 2023-04-01 to
2023-09-30
2022-04-01 to
2022-09-30
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
-301,233,000 JPY
-366,550,000 JPY
Non-operating income
Non-operating income
857,000 JPY
25,727,000 JPY
Non-operating expenses
Non-operating expenses
3,303,000 JPY
1,507,000 JPY
Ordinary profit (loss)
-303,679,000 JPY
-342,330,000 JPY
Extraordinary losses
Extraordinary losses
750,000 JPY
JPY
Profit (loss) before income taxes
-304,430,000 JPY
-342,330,000 JPY
Income taxes - current
1,425,000 JPY
1,815,000 JPY
Profit (loss)
-305,856,000 JPY
-344,145,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.